Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Henan Cancer Hospital)"
Count: 203
Selected: 0
| NCT ID | Title |
|---|
| NCT03881774 | Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies | ||
| NCT03881761 | CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma | ||
| NCT05282563 | Clinical Study on the Safety of Double and a Half Layered Esophagojejunal Anastomosis in Curative Gastrectomy | ||
| NCT02395705 | Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma | ||
| NCT02621333 | Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma | ||
| NCT05769010 | Study of SHR-A1811 in HER2-positive Advanced Breast Cancer With Brain Metastases | ||
| NCT05747521 | Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma | ||
| NCT05718778 | Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma | ||
| NCT05647330 | Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer | ||
| NCT05640713 | Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy | ||
| NCT05617859 | Lenvatinib for Advanced Bone and Soft Tissue Sarcoma | ||
| NCT05617846 | Application of Antiosteoporosis Therapy in Osteolysis | ||
| NCT05616195 | Application of 3D Printed Prosthesis in Limb Salvage Surgery for Bone Tumors | ||
| NCT05616182 | Application of LARS Ligament in Bone Prosthesis Replacement | ||
| NCT05615545 | Cryoablation for Advanced Bone and Soft Tissue Tumors | ||
| NCT05608785 | Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes | ||
| NCT05598827 | Application of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During Perichemotherapy | ||
| NCT05598229 | Application of Douyin in Perioperative Period of Malignant Tumor Patients | ||
| NCT05596344 | Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors | ||
| NCT05583383 | A Study of the Advanced Adenocarcinoma of Stomach and Gastroesophageal Junction With Camrelizumab+SOX Control Camrelizumab+SOX+ Trastuzumab | ||
| NCT05569668 | Neoadjuvant Chemotherapy Compared With Surgery for Esophageal Carcinoma | ||
| NCT05547737 | Multicenter, Prospective, Real World Study of Camrelizumab in Cross-line Treatment of Non-small Cell Lung Cancer | ||
| NCT05545124 | Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence | ||
| NCT05495152 | Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma | ||
| NCT05490667 | Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor | ||
| NCT05490485 | Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma | ||
| NCT05475938 | Application of Painting Analysis and Psychotherapy in Children With Bone Tumors | ||
| NCT05474690 | A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer | ||
| NCT05468970 | Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors | ||
| NCT05466474 | PD-1 Antibody Tislelizumab Combined With Dacarbazine in the Treatment of Advanced Melanoma | ||
| NCT05453409 | Study on Clinical Features, Treatment Mode and Survival of Sarcoma | ||
| NCT05442138 | A Study on the Potential Benefit of Neoadjuvant Therapy for AGC Patients | ||
| NCT05398861 | Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer | ||
| NCT05394285 | A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Chemotherapy in Advanced Breast Cancer | ||
| NCT05380986 | Camrelizumab Combined With Apatinib Mesylate | ||
| NCT05377658 | AK104 Monotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer | ||
| NCT05359120 | Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE) | ||
| NCT05357417 | Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases | ||
| NCT05335473 | Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure | ||
| NCT05328440 | Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02) | ||
| NCT05313906 | RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer | ||
| NCT05299255 | Utidelone in Third-line and Above Treatment of Small Cell Lung Cancer | ||
| NCT05296577 | Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer | ||
| NCT05276167 | Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial Carcinoma | ||
| NCT05252091 | An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC | ||
| NCT05242874 | Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer | ||
| NCT05209620 | Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma | ||
| NCT05207735 | PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma. | ||
| NCT05189483 | Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma. | ||
| NCT05177068 | Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer |
